Meeting
2023 ASCO Genitourinary Cancers Symposium
Heterogeneity in physician and patient preferences for the treatment of renal cell carcinoma: Evidence from latent class analysis.
Authors
Caroline Vass
RTI Health Solutions, Manchester, United Kingdom
Caroline Vass , Cathy Anne Pinto , Kelley Myers , Kentaro Imai , Cooper Bussberg , Rituparna Bhattacharya , Shawna R Calhoun , Christine Poulos
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer
Sub Track
Symptoms, Toxicities, Patient-Reported Outcomes, and Whole-Person Care
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 661)
DOI
10.1200/JCO.2023.41.6_suppl.661
Abstract #
661
Poster Bd #
G12
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Patient and physician preferences for adjuvant treatment of renal cell carcinoma: A discrete-choice experiment.
First Author: Shawna R Calhoun
Poster
2023 ASCO Genitourinary Cancers Symposium
Assessing treatment preferences among patients with advanced/metastatic renal cell carcinoma in the United States: A discrete choice experiment.
First Author: Moshe Chaim Ornstein
Poster
2023 ASCO Genitourinary Cancers Symposium
Immune checkpoint inhibitors in the peri-operative setting in renal cell carcinoma: A meta-analysis of the randomized clinical trials.
First Author: Jorge Esteban Villarrubia
Poster
2022 ASCO Genitourinary Cancers Symposium
Effect of neoadjuvant chemotherapy (NAC) on patient preferences for adjuvant treatment in muscle-invasive urothelial carcinoma (MIUC): A multi-country discrete choice experiment (DCE).
First Author: Edward I Broughton